These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 24990699)

  • 1. Apelin/APJ system: a promising therapy target for hypertension.
    Wu D; He L; Chen L
    Mol Biol Rep; 2014 Oct; 41(10):6691-703. PubMed ID: 24990699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apelin and its receptor expression in adipose tissues of obesity rats with hypertension and cultured 3T3-L1 adipocytes.
    Wu H; Cheng XW; Hao C; Zhang Z; Yao H; Murohara T; Dai Q
    Exp Anim; 2014; 63(2):257-67. PubMed ID: 24770651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting drugs to APJ receptor: the prospect of treatment of hypertension and other cardiovascular diseases.
    Cao J; Li H; Chen L
    Curr Drug Targets; 2015; 16(2):148-55. PubMed ID: 25438973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.
    Lv D; Li H; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):527-33. PubMed ID: 23588025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin and its receptor APJ in cardiovascular diseases.
    Yu XH; Tang ZB; Liu LJ; Qian H; Tang SL; Zhang DW; Tian GP; Tang CK
    Clin Chim Acta; 2014 Jan; 428():1-8. PubMed ID: 24055369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational promise of the apelin--APJ system.
    Barnes G; Japp AG; Newby DE
    Heart; 2010 Jul; 96(13):1011-6. PubMed ID: 20584856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure.
    Barnes GD; Alam S; Carter G; Pedersen CM; Lee KM; Hubbard TJ; Veitch S; Jeong H; White A; Cruden NL; Huson L; Japp AG; Newby DE
    Circ Heart Fail; 2013 May; 6(3):482-91. PubMed ID: 23519586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury.
    Chen Z; Wu D; Li L; Chen L
    DNA Cell Biol; 2016 Dec; 35(12):766-775. PubMed ID: 27854125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin-13 and APJ in paraventricular nucleus contribute to hypertension via sympathetic activation and vasopressin release in spontaneously hypertensive rats.
    Zhang F; Sun HJ; Xiong XQ; Chen Q; Li YH; Kang YM; Wang JJ; Gao XY; Zhu GQ
    Acta Physiol (Oxf); 2014 Sep; 212(1):17-27. PubMed ID: 24995933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.
    Chu J; Zhang H; Huang X; Lin Y; Shen T; Chen B; Man Y; Wang S; Li J
    PLoS One; 2013; 8(2):e57231. PubMed ID: 23437347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin/APJ system: A novel therapeutic target for oxidative stress-related inflammatory diseases (Review).
    Zhou Q; Cao J; Chen L
    Int J Mol Med; 2016 May; 37(5):1159-69. PubMed ID: 27035220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APJ polymorphisms in coronary artery disease patients with and without hypertension.
    Falcone C; Bozzini S; Schirinzi S; Buzzi MP; Boiocchi C; Totaro R; Bondesan M; Pelissero G
    Mol Med Rep; 2012 Feb; 5(2):321-5. PubMed ID: 22109355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.
    Chapman NA; Dupré DJ; Rainey JK
    Biochem Cell Biol; 2014 Dec; 92(6):431-40. PubMed ID: 25275559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apelin--a new protein-regulator in the cardiovascular system].
    Tereshchenko SN; Masenko VP; Cherkavskaia OV; Shashkova NV
    Ter Arkh; 2009; 81(9):68-72. PubMed ID: 19827657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The apelin/APJ system in the regulation of vascular tone: friend or foe?
    Rikitake Y
    J Biochem; 2021 Apr; 169(4):383-386. PubMed ID: 33169143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apelin/APJ signaling in hypoxia-related diseases.
    He L; Xu J; Chen L; Li L
    Clin Chim Acta; 2015 Dec; 451(Pt B):191-8. PubMed ID: 26436483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys.
    Soltani Hekmat A; Najafipour H; Nekooian AA; Esmaeli-Mahani S; Javanmardi K
    Regul Pept; 2011 Dec; 172(1-3):62-8. PubMed ID: 21911011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity.
    Hamada J; Baasanjav A; Ono N; Murata K; Kako K; Ishida J; Fukamizu A
    Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H931-41. PubMed ID: 25681427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.
    Kang Y; Kim J; Anderson JP; Wu J; Gleim SR; Kundu RK; McLean DL; Kim JD; Park H; Jin SW; Hwa J; Quertermous T; Chun HJ
    Circ Res; 2013 Jun; 113(1):22-31. PubMed ID: 23603510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.